Group One Trading’s Orphazyme A/S ORPH Stock Holding History

Group One Trading’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-286,400	Closed	-$690K	–	9096
2021 Q4	$690K	Buy	286,400 +154,300	+117%	+$545K	﹤0.01%	3753
2021 Q3	$543K	Buy	132,100 +82,100	+164%	+$422K	﹤0.01%	4105
2021 Q2	$368K	Buy	+50,000	New	+$403K	﹤0.01%	4564

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Group One Trading's ORPH Position: Q1 2022 in Review

Group One Trading sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 19,922 shares — an estimated $48K sold.

Group One Trading first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $63K in Q2 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Group One Trading reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Group One Trading sold 19,922 Orphazyme A/S shares in Q1 2022, an estimated $48K.
Group One Trading first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Group One Trading's Orphazyme A/S position peaked at $63K in Q2 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.